Preoperative Serum Calcitonin Thresholds as Predictors of Lymph Node Metastasis in Thyroid Cancer
Updated serum calcitonin thresholds effectively predict lymph node metastasis in medullary thyroid cancer, aiding surgical decision-making and personalized treatment strategies.
Recent research published in the August issue of JAMA Otolaryngology–Head & Neck Surgery highlights the significance of preoperative serum calcitonin levels in predicting the extent of lymph node metastasis (LNM) in patients with medullary thyroid cancer (MTC). The study, conducted by Yuxin Du, M.D., and colleagues from Fudan University Shanghai Cancer Center, provides updated threshold values for basal serum calcitonin that correlate with different levels of lymph node involvement.
Involving 509 patients with newly treated MTC, the retrospective cohort study analyzed preoperative calcitonin levels measured through electrochemiluminescence or chemiluminescence between 2011 and 2024. Patients were categorized based on the extent of LNM: no metastasis, central LNM, lateral LNM, and upper mediastinal LNM. The findings revealed that higher baseline calcitonin levels are positively associated with more extensive lymph node involvement.
Using data from the training cohort, researchers identified specific calcitonin thresholds that predict varying LNM extents: 241.9 pg/mL for central LNM, 693.9 pg/mL for ipsilateral lateral LNM, 2,787.1 pg/mL for upper mediastinal LNM, and 2,378.5 pg/mL for bilateral or contralateral lateral LNM. Notably, these thresholds outperformed current guidelines by the American Thyroid Association in predicting LNM and assessing the likelihood of structural recurrence-free survival.
The study underscores the potential of using preoperative calcitonin levels to guide surgical decision-making, especially regarding the scope of neck dissection in MTC cases. The authors emphasize that these findings establish a solid theoretical foundation for future prospective clinical trials aimed at optimizing surgical strategies based on calcitonin thresholds.
For more detailed information, refer to the publication: DOI: 10.1001/jamaoto.2025.0542. The research contributes to advancing personalized management of thyroid cancer and may influence future clinical guidelines.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Emerging Trends: How Direct-to-Consumer Drug Pricing Could Challenge Traditional Prescription Insurance
A new study explores how direct-to-consumer online pharmacies could significantly reduce medication costs and disrupt traditional prescription insurance models, offering affordable options for uninsured and insured alike.
Understanding Glucose Transport Failures in Type 2 Diabetes
Research reveals how impaired GLUT transporter trafficking in pancreatic β-cells contributes to decreased insulin secretion in type 2 diabetes, opening new therapeutic possibilities.
Abnormal Fusion Protein Creates Cell Droplets That May Promote Childhood Brain Tumors
Scientists have uncovered how an abnormal fusion protein causes cell droplet formation, potentially driving childhood brain tumors like ependymoma. This discovery opens new possibilities for targeted therapies in difficult-to-treat cancers.
How Childhood Environment Influences Brain's Risk-Taking Behavior
New research reveals that early social and economic environments shape how the brain processes risk, affecting decision-making strategies into adulthood.